215 related articles for article (PubMed ID: 15244167)
1. [Neurotoxic effects of medications: an update].
Arné-Bès MC
Rev Med Liege; 2004; 59 Suppl 1():118-23. PubMed ID: 15244167
[TBL] [Abstract][Full Text] [Related]
2. Advances in understanding drug-induced neuropathies.
Peltier AC; Russell JW
Drug Saf; 2006; 29(1):23-30. PubMed ID: 16454532
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in drug-induced neuropathies.
Peltier AC; Russell JW
Curr Opin Neurol; 2002 Oct; 15(5):633-8. PubMed ID: 12352008
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy.
Molassiotis A; Cheng HL; Leung KT; Li YC; Wong KH; Au JSK; Sundar R; Chan A; Ng TR; Suen LKP; Chan CW; Yorke J; Lopez V
Brain Behav; 2019 Jun; 9(6):e01312. PubMed ID: 31063261
[TBL] [Abstract][Full Text] [Related]
5. [Drug induced neuropathies].
Lagueny A
Rev Prat; 2008 Nov; 58(17):1910-6. PubMed ID: 19157207
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-induced peripheral neuropathy.
Quasthoff S; Hartung HP
J Neurol; 2002 Jan; 249(1):9-17. PubMed ID: 11954874
[TBL] [Abstract][Full Text] [Related]
7. Toxic neuropathy.
Umapathi T; Chaudhry V
Curr Opin Neurol; 2005 Oct; 18(5):574-80. PubMed ID: 16155443
[TBL] [Abstract][Full Text] [Related]
8. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.
Amara S
Ann Pharmacother; 2008 Oct; 42(10):1481-5. PubMed ID: 18698011
[TBL] [Abstract][Full Text] [Related]
9. Platinum-induced peripheral neurotoxicity: From pathogenesis to treatment.
Staff NP; Cavaletti G; Islam B; Lustberg M; Psimaras D; Tamburin S
J Peripher Nerv Syst; 2019 Oct; 24 Suppl 2(Suppl 2):S26-S39. PubMed ID: 31647151
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy-Induced Peripheral Neuropathy in Long-term Survivors of Childhood Cancer: Clinical, Neurophysiological, Functional, and Patient-Reported Outcomes.
Kandula T; Farrar MA; Cohn RJ; Mizrahi D; Carey K; Johnston K; Kiernan MC; Krishnan AV; Park SB
JAMA Neurol; 2018 Aug; 75(8):980-988. PubMed ID: 29799906
[TBL] [Abstract][Full Text] [Related]
11. [[Peripheral nervous system neurotoxicity secondary to chemotherapy treatment] ].
Iñiguez C; Larrodé P; Mayordomo JI; Mauri JA; Trés A; Morales F
Neurologia; 2000 Oct; 15(8):343-51. PubMed ID: 11143501
[TBL] [Abstract][Full Text] [Related]
12. Vinca alkaloids, thalidomide and eribulin-induced peripheral neurotoxicity: From pathogenesis to treatment.
Islam B; Lustberg M; Staff NP; Kolb N; Alberti P; Argyriou AA
J Peripher Nerv Syst; 2019 Oct; 24 Suppl 2():S63-S73. PubMed ID: 31647152
[TBL] [Abstract][Full Text] [Related]
13. [Neuropathy induced by antineoplastic drugs].
Kusunoki J; Saito T
Brain Nerve; 2008 Feb; 60(2):131-6. PubMed ID: 18306660
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies.
Park SB; Krishnan AV; Lin CS; Goldstein D; Friedlander M; Kiernan MC
Curr Med Chem; 2008; 15(29):3081-94. PubMed ID: 19075655
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy-induced peripheral neurotoxicity.
Cavaletti G; Marmiroli P
Expert Opin Drug Saf; 2004 Nov; 3(6):535-46. PubMed ID: 15500413
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy-induced neuropathies-a growing problem for patients and health care providers.
Banach M; Juranek JK; Zygulska AL
Brain Behav; 2017 Jan; 7(1):e00558. PubMed ID: 28127506
[TBL] [Abstract][Full Text] [Related]
17. Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials.
Hershman DL; Till C; Wright JD; Awad D; Ramsey SD; Barlow WE; Minasian LM; Unger J
J Clin Oncol; 2016 Sep; 34(25):3014-22. PubMed ID: 27325863
[TBL] [Abstract][Full Text] [Related]
18. Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy.
Fumagalli G; Monza L; Cavaletti G; Rigolio R; Meregalli C
Front Immunol; 2020; 11():626687. PubMed ID: 33613570
[TBL] [Abstract][Full Text] [Related]
19. Taxane-induced peripheral neuropathy has good long-term prognosis: a 1- to 13-year evaluation.
Osmani K; Vignes S; Aissi M; Wade F; Milani P; Lévy BI; Kubis N
J Neurol; 2012 Sep; 259(9):1936-43. PubMed ID: 22349867
[TBL] [Abstract][Full Text] [Related]
20. The validity of neuropathy and neuropathic pain measures in patients with cancer receiving taxanes and platinums.
Lavoie Smith EM; Cohen JA; Pett MA; Beck SL
Oncol Nurs Forum; 2011 Mar; 38(2):133-42. PubMed ID: 21356652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
